文献速递肿瘤 PET/CT神经核医学甲状腺核医学

男性乳腺癌神经内分泌变异型以垂体症状首发:68Ga-DOTATATE PET/CT检出

Unusual Variant of Breast Cancer Presenting With Pituitary Symptoms Detected on 68Ga-DOTATATE PET/CT.
PubMed 文献 · Clin Nucl Med · 2021-01-01

本文报道一例57岁男性,以垂体症状起病,68Ga-DOTANOC PET/CT显示垂体病灶为转移灶,并发现乳腺原发灶及其他部位生长抑素表达病灶,组织病理证实乳腺癌伴神经内分泌分化。乳腺神经内分泌分化癌极为罕见,男性尤为少见,文献几乎空白。

要点

  • 男性乳腺癌神经内分泌变异型极罕见,常以转移灶症状起病。
  • 生长抑素受体PET/CT可同时显示垂体转移与乳腺原发等多发病灶。
  • 确诊依赖组织病理证实神经内分泌分化。

核心结论

  • 乳腺癌伴神经内分泌分化在男性中极为罕见,可表现为垂体转移症状,68Ga-DOTANOC PET/CT有助于全身病灶检出,最终需病理证实神经内分泌分化。

研究设计与样本

  • 个案报道:1例57岁男性,以垂体症状就诊,行68Ga-DOTANOC PET/CT显像并取得组织病理证实。

主要发现

  • 68Ga-DOTANOC PET/CT显示垂体病灶为转移灶,乳腺为生长抑素表达的原发灶,并见其他部位病灶,病理证实乳腺癌伴神经内分泌分化。

临床怎么用

  • 对表现垂体症状且怀疑转移的男性患者,可考虑生长抑素受体PET/CT评估生长抑素表达病灶并寻找原发灶,确诊依赖病理。

局限性

  • 为单一病例报道,证据级别有限,不能推广为普遍诊疗推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Carcinoma of breast with neuroendocrine differentiation is an extremely rare entity, especially in male population. Although the "garden variety" of male breast cancers is often metastatic at presentation, with an aggressive course, there is hardly any literature about neuroendocrine variants. We report a case of a 57-year-old man who had pituitary symptoms, which on 68Ga-DOTANOC PET/CT imaging turned out to be a metastatic lesion, with somatostatin expressing primary in breast and other sites, with histopathological confirmation of neuroendocrine differentiation in breast cancer.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Dev ID, Puranik AD, Rangarajan V, et al. Unusual Variant of Breast Cancer Presenting With Pituitary Symptoms Detected on 68Ga-DOTATATE PET/CT. Clin Nucl Med. 2021. PMID: 34172604. doi:10.1097/RLU.0000000000003768

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。